← Snapshot 21

Orange Book snapshot 21: Products

Products page 72 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
3552A076823003LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEABLE600MG[]2004-06-29Jun 29, 2004NoNoNoDISCNABLE LABORATORIES INC90be44a7845c8d842859ab8762675496027f58eb852c0bb9230383dfcd257eb5
3553A079159001LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEALEMBIC LTD150MGAB["AB"]2009-01-12Jan 12, 2009NoNoNoRXALEMBIC LTD66c3f20cda735d5dc04e261f3f10bf1725c82a5693c031037835b2ad4e82c89a
3554A079159002LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEALEMBIC LTD300MGAB["AB"]2009-01-12Jan 12, 2009NoNoNoRXALEMBIC LTD9ee0dc5e6dbddf9491db6b6c391f3deedfc942ee85233f9b5def5433cdb728fc
3555A079159003LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEALEMBIC LTD600MGAB["AB"]2009-01-12Jan 12, 2009NoNoNoRXALEMBIC LTD9215f6ac87b074c47eb65bed0c59fdae406eefa177a13f269da4efb6a2d107ce
3556A076795001LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEAPOTEX INC300MG[]2004-11-22Nov 22, 2004NoNoNoDISCNAPOTEX INC5841e60545593134f8b8679952f6209413234702c0a0dd543b95504c00968329
3557A079139001LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEGLENMARK GENERICS150MGAB["AB"]2009-02-03Feb 3, 2009NoNoNoRXGLENMARK GENERICS LTDc54befc96cd6513f7ea4f41c8bbd747e32a37b466073f963e52b31e0f01991dd
3558A079139002LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEGLENMARK GENERICS300MGAB["AB"]2009-02-03Feb 3, 2009NoNoNoRXGLENMARK GENERICS LTD79dff90645a21607a6bcb9a03e576d9f5c13663c35842b7530e424f6517a11c6
3559A079139003LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEGLENMARK GENERICS600MGAB["AB"]2009-02-03Feb 3, 2009NoNoNoRXGLENMARK GENERICS LTD8c7c35b457984e1314b4e1e8ab6fe8227412e47b0378132b6dde58ffe9624485
3560A090702001LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEHETERO LABS LTD III150MGAB["AB"]2009-09-25Sep 25, 2009NoNoNoRXHETERO LABS LTD UNIT IIId9eae0208c6b7a43e26386b3c72a457536f6811f571317aee5a6d889308d744c
3561A090702002LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEHETERO LABS LTD III300MGAB["AB"]2009-09-25Sep 25, 2009NoNoNoRXHETERO LABS LTD UNIT III278722dea6efaad0dc87a2d0d74883cd689a2fb3490c441d89cc04f7df57b6dc
3562A090702003LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEHETERO LABS LTD III600MGAB["AB"]2009-09-25Sep 25, 2009NoNoNoRXHETERO LABS LTD UNIT III5840b93fa8d7a29e3d5f107413f07ba2982bf7a6e6266b86de7546f070ebd149
3563N017812002LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEHIKMA150MGAB["AB"]1987-01-28Jan 28, 1987NoYesNoRXHIKMA PHARMACEUTICALS USA INC173c292d35cbda4adca724d5edd20e53d8b02cecd9f83ebbd35fc00c05a9eb16
3564N017812001LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEHIKMA300MGAB["AB"]Approved Prior to Jan 1, 1982YesYesNoRXHIKMA PHARMACEUTICALS USA INC9b2b5d5a34d46438711668a409f8d296d91d117fb987be9fd4790719eb54072c
3565N017812003LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEHIKMA600MGAB["AB"]1987-01-28Jan 28, 1987NoYesYesRXHIKMA PHARMACEUTICALS USA INCc0d9cae625599669df4336b971a7f7cf0730d59e7ee7235a47052229d37debd8
3566A076243002LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEMYLAN150MG[]2003-02-24Feb 24, 2003NoNoNoDISCNMYLAN PHARMACEUTICALS INC241c6c6a3bb51728ef78cedf132c2566de10341adaadb965e919ee248837921e
3567A076243001LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEMYLAN300MG[]2002-06-27Jun 27, 2002NoNoNoDISCNMYLAN PHARMACEUTICALS INC7718d959a990f4ca19c709926e95cd8714edc697ea94a3a9f976d5a79391a110
3568A078763001LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEMYLAN600MG[]2008-04-15Apr 15, 2008NoNoNoDISCNMYLAN PHARMACEUTICALS INC94e6569688ce4cb161e339139d0bba150ad40526a82214a68b1f0d7ffdc9d30f
3569A072542001LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEUSL PHARMA300MG[]1989-02-01Feb 1, 1989NoNoNoDISCNUSL PHARMA INC1ef7a43e868aa532ef05b5eccd0bf423bf404067f4714f210b6bbd3356da3e28
3570A070407001LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHIUM CARBONATEWATSON LABS300MG[]1987-03-19Mar 19, 1987NoNoNoDISCNWATSON LABORATORIES INC6b94412d01d6843be2893d70fc5dfbc1a09453303a323ab80e21cf3e8538ac38
3571N016782001LITHIUM CARBONATECAPSULE;ORALCAPSULEORALLITHONATESOLVAY300MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNSOLVAY PHARMACEUTICALSb3ef257123b3f7b5b16b994b9eb6fb3c92c969c18294432a4d9fe2cd41ccaaa4
3572N018922002ETODOLACCAPSULE;ORALCAPSULEORALLODINEWYETH PHARMS INC200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]1991-01-31Jan 31, 1991NoYesNoDISCNWYETH PHARMACEUTICALS INC8a809b9f94376e7142ba68cac21e9d4596ed6aae1c74fea4c3e5e15e4826895d
3573N018922003ETODOLACCAPSULE;ORALCAPSULEORALLODINEWYETH PHARMS INC300MG[]1991-01-31Jan 31, 1991NoYesNoDISCNWYETH PHARMACEUTICALS INC8b688d43707d94077c1dedef7858e2795af01546f341d0d2e20fb1db5ac1a6f6
3574N021855001LOPERAMIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOPERAMIDE HYDROCHLORIDEBIONPHARMA INC1MG[]2005-08-04Aug 4, 2005NoYesNoOTCBIONPHARMA INCba0dba8ee4a4308655e8200f4ab338f48cf53db9a5662ceff5b93f7b20af7b2d
3575N021855002LOPERAMIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOPERAMIDE HYDROCHLORIDEBIONPHARMA INC2MG[]2005-08-04Aug 4, 2005NoYesYesOTCBIONPHARMA INC4284783650027289f4ddfea19013bbbb99a24ff52fb9f6bc63a98e1e197bd747
3576A072741001LOPERAMIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOPERAMIDE HYDROCHLORIDEMYLAN2MGAB["AB"]1991-09-18Sep 18, 1991NoNoYesRXMYLAN PHARMACEUTICALS INC2e84b4dc17e89c6c806ad473c47a87f8ae537af480a5d06c6ff0450d85258b0e
3577A073080001LOPERAMIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOPERAMIDE HYDROCHLORIDEROXANE2MG[]1991-11-27Nov 27, 1991NoNoNoDISCNROXANE LABORATORIES INCf7a0bac69c851ed19de454517bac6d98b669487f44f939f51c626f213a29ba38
3578A073122001LOPERAMIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOPERAMIDE HYDROCHLORIDETEVA2MG[]1991-08-30Aug 30, 1991NoNoNoDISCNTEVA PHARMACEUTICALS USA INC518a57112687a996c4a800d507870945a062197608374d12fc71829c651dcd6b
3579A073192001LOPERAMIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOPERAMIDE HYDROCHLORIDETEVA2MGAB["AB"]1992-04-30Apr 30, 1992NoNoNoRXTEVA PHARMACEUTICALS USA INC35a858b9e3bd12e728bdceddc6efc2f8ef44f871e067307e6c90ab418c183286
3580A072993001LOPERAMIDE HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOPERAMIDE HYDROCHLORIDEYAOPHARMA CO LTD2MG[]1992-08-28Aug 28, 1992NoNoNoDISCNYAOPHARMA CO LTD460b93dd670337fedcb2373a09fac74ebe1dedaa4b933951d7f046c74ff936b5
3581N018422001GEMFIBROZILCAPSULE;ORALCAPSULEORALLOPIDPFIZER PHARMS200MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNPFIZER PHARMACEUTICALS LTD189234563721fef402807ade1010a96ebe3ba67110185c6b72d2c5fda1e18e9c
3582N018422002GEMFIBROZILCAPSULE;ORALCAPSULEORALLOPIDPFIZER PHARMS300MG[]Approved Prior to Jan 1, 1982YesNoNoDISCNPFIZER PHARMACEUTICALS LTD2128d1345d876b4d9c9ac535e157ae978915abdd5990bcaaa0520482ee917c30
3583N019451001CHLORTHALIDONE; METOPROLOL TARTRATECAPSULE;ORALCAPSULEORALLOPRESSIDONENOVARTIS25MG;100MG[]1987-12-31Dec 31, 1987NoNoNoDISCNNOVARTIS PHARMACEUTICALS CORPbaf2125aff558b34f306d6fac1d6a8cba8ce418d544ff3e8de198c5f7b0f82f3
3584N019451002CHLORTHALIDONE; METOPROLOL TARTRATECAPSULE;ORALCAPSULEORALLOPRESSIDONENOVARTIS25MG;200MG[]1987-12-31Dec 31, 1987NoNoNoDISCNNOVARTIS PHARMACEUTICALS CORPe542c91b29772981d52bb359c532c63d9df8b47e2d1b0c8472ff52a69c293edf
3585N050668001LORACARBEFCAPSULE;ORALCAPSULEORALLORABIDKING PHARMS200MG[]1991-12-31Dec 31, 1991NoNoNoDISCNKING PHARMACEUTICALS INC30aa16ec554bc69afa76f05487e1912c62a13b9affbfc8c609063c764dc6e5cb
3586N050668002LORACARBEFCAPSULE;ORALCAPSULEORALLORABIDKING PHARMS400MG[]1996-04-05Apr 5, 1996NoNoNoDISCNKING PHARMACEUTICALS INC69dbadee05e73833cbcc9808abd6e8c5541c36fea3ca11ce0931dd01a76d5194
3587A202538001LORATADINECAPSULE;ORALCAPSULEORALLORATADINEBIONPHARMA INC10MG[]2018-12-21Dec 21, 2018NoNoNoOTCBIONPHARMA INCb6fbe77342632a85532f5e2e2cb398ea4fca42e610fca83ee6a32745ab9284ab
3588A206214001LORATADINECAPSULE;ORALCAPSULEORALLORATADINEMARKSANS PHARMA10MG[]2016-09-23Sep 23, 2016NoNoNoOTCMARKSANS PHARMA LTD3867354d3ccdfa5332f49ac5da57dbf78cc8deb9143c96d1af4abdc82ac2613f
3589A211926001LORATADINECAPSULE;ORALCAPSULEORALLORATADINESTRIDES PHARMA10MG[]2020-01-15Jan 15, 2020NoNoNoDISCNSTRIDES PHARMA GLOBAL PTE LTD34bfc5094f04e6d9a4882c9aebce6df7952a5da7be4d60b852d5cb90698e1c54
3590A087336001ACETAMINOPHEN; HYDROCODONE BITARTRATECAPSULE;ORALCAPSULEORALLORCET-HDMALLINCKRODT500MG;5MG[]1982-07-08Jul 8, 1982NoNoNoDISCNMALLINCKRODT CHEMICAL INCdb63b31fa7bc28b06c89eaa7faf0299986a5dd848472ab65587be89e22cf0bc2
3591N020364002AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOTRELNOVARTISEQ 2.5MG BASE;10MGAB["AB"]1995-03-03Mar 3, 1995NoYesNoRXNOVARTIS PHARMACEUTICALS CORP72ed5f4f7fda748cf1ed01635cb92c8a81b07c8b5b46a7b9fd0661b3b29326b5
3592N020364003AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOTRELNOVARTISEQ 5MG BASE;10MGAB["AB"]1995-03-03Mar 3, 1995NoYesNoRXNOVARTIS PHARMACEUTICALS CORPccce94b86b9871de43ca9c7aaceade1bb6aeeb248d9d656fd2e16f9def770542
3593N020364004AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOTRELNOVARTISEQ 5MG BASE;20MGAB["AB"]1995-03-03Mar 3, 1995NoYesNoRXNOVARTIS PHARMACEUTICALS CORPe7b2220b9095064556279a6908c37e7b144b35199962b1dd721f68eea7d8e857
3594N020364007AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOTRELNOVARTISEQ 5MG BASE;40MGAB["AB"]2006-04-11Apr 11, 2006NoYesNoRXNOVARTIS PHARMACEUTICALS CORPe1a75567cdea2f8d169d4066f81ea6578895bf95d0b14924e89baaa7fcc15d64
3595N020364005AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOTRELNOVARTISEQ 10MG BASE;20MGAB["AB"]2002-06-20Jun 20, 2002NoYesNoRXNOVARTIS PHARMACEUTICALS CORP4af570d66e155bcb59f1ab7ce40066cf8949da5660889519395bf99b1d3b8db8
3596N020364006AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDECAPSULE;ORALCAPSULEORALLOTRELNOVARTISEQ 10MG BASE;40MGAB["AB"]2006-04-11Apr 11, 2006NoYesYesRXNOVARTIS PHARMACEUTICALS CORPa41aff991d911e398e26280ec3efb3a3f85334998faefcb5fdd276dcd2aa2ec5
3597N021654001OMEGA-3-ACID ETHYL ESTERSCAPSULE;ORALCAPSULEORALLOVAZAWOODWARD1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDSAB["AB"]2004-11-10Nov 10, 2004NoYesYesRXWOODWARD PHARMA SERVICES LLC13e08a5a5f514c67b58d96716f189c3a1d0144e704cdc844198e6cb06d7aeee0
3598A076868001LOXAPINE SUCCINATECAPSULE;ORALCAPSULEORALLOXAPINE SUCCINATEELITE LABS INCEQ 5MG BASEAB["AB"]2005-08-04Aug 4, 2005NoNoNoRXELITE LABORATORIES INC94b3714a57a4484260c4c54d0162a9b359d993b1965ac1a9c874fc05a3adf03d
3599A076868002LOXAPINE SUCCINATECAPSULE;ORALCAPSULEORALLOXAPINE SUCCINATEELITE LABS INCEQ 10MG BASEAB["AB"]2005-08-04Aug 4, 2005NoNoNoRXELITE LABORATORIES INC4f6d5e5d328c1c67c186f839923d49dac6e05b4445708e6086d7d88f45b729a0
3600A076868003LOXAPINE SUCCINATECAPSULE;ORALCAPSULEORALLOXAPINE SUCCINATEELITE LABS INCEQ 25MG BASEAB["AB"]2005-08-04Aug 4, 2005NoNoNoRXELITE LABORATORIES INCe47b6cf9db6b2f075622e42e9944af45169b839a62d354627e4d45472262eaed
3601A076868004LOXAPINE SUCCINATECAPSULE;ORALCAPSULEORALLOXAPINE SUCCINATEELITE LABS INCEQ 50MG BASEAB["AB"]2005-08-04Aug 4, 2005NoNoNoRXELITE LABORATORIES INCf11b2f6b1f23b49dfcfb9a4bbacc694b8efcdb8c3136523a24508cbd2ba6fe4f